Consider clear-lens extraction first-line treatment for PACG
Clear-lens extraction improved overall health status, visual impairment and disability, and glaucoma-specific disability in primary angle closure and primary angle-closure glaucoma, according to researchers in The Lancet.
Of 419 patients enrolled from 30 hospital eye services in five countries, 155 had primary angle closure and 263 had primary angle-closure glaucoma (PACG). A total of 208 were assigned to clear-lens extraction and 211 to standard care.
European Quality of Life-5 Dimensions scores and intraocular pressure at 36 months significantly favored the clear-lens extraction group, according to the study.
National Eye Institute Visual Function Questionnaire-25 and Glaucoma Utility Index scores at 36 months were significantly higher in the clear-lens extraction group than in the standard care group.
Significantly fewer patients in the clear-lens extraction group needed treatment to control IOP, and fewer needed glaucoma medications than patients who received standard care, researchers found.
At 3 years, the mean IOP was about 1 mm Hg lower in the clear-lens extraction group.
The clear-lens extraction group showed higher total quality-adjusted life-years, and the procedure was more cost-effective than laser peripheral iridotomy.
“...the consistent superiority of clear-lens extractions in terms of patient-reported and clinical benefits and the absence of serious safety issues provide strong support for considering this approach as the first-line treatment for individuals with primary angle-closure disease,” researchers wrote. – by Abigail Sutton
Disclosure: The researchers reported no relevant financial disclosures.